Intervention Review

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

  1. Michal Rolinski1,*,
  2. Chris Fox2,
  3. Ian Maidment3,
  4. Rupert McShane4

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 14 MAR 2012

Assessed as up-to-date: 30 AUG 2011

DOI: 10.1002/14651858.CD006504.pub2


How to Cite

Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD006504. DOI: 10.1002/14651858.CD006504.pub2.

Author Information

  1. 1

    Nuffield Department of Clinical Neurosciences, Oxford, UK

  2. 2

    Norwich Medical School, Norwich, UK

  3. 3

    Kent and Medway NHS and Social Care Partnership Trust, Pharmacy Department, Canterbury, Kent, UK

  4. 4

    University of Oxford, Radcliffe Department of Medicine, Oxford, Oxfordshire, UK

*Michal Rolinski, Nuffield Department of Clinical Neurosciences, Level 6, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, UK. michal.rolinski@ndcn.ox.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions), comment added to review
  2. Published Online: 14 MAR 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kerry L. Hildreth, Skotti Church, Evaluation and Management of the Elderly Patient Presenting with Cognitive Complaints, Medical Clinics of North America, 2015, 99, 2, 311

    CrossRef

  2. 2
    Maleeha Waqar, Sidra Batool, In silico analysis of binding of neurotoxic venom ligands with acetylcholinesterase for therapeutic use in treatment of Alzheimer’s disease, Journal of Theoretical Biology, 2015, 372, 107

    CrossRef

  3. 3
    A. Robles Bayón, F. Gude Sampedro, Síntomas conductuales y psiquiátricos en neurología cognitiva, Neurología, 2015,

    CrossRef

  4. 4
    Michael Hüll, Hans Förstl, Psychische Erkrankungen, 2015,

    CrossRef

  5. 5
    Therapie Psychischer Erkrankungen, 2015,

    CrossRef

  6. 6
    L. F. Morra, P. J. Donovick, Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review, International Journal of Geriatric Psychiatry, 2014, 29, 6
  7. 7
    Yongxing Yan, Lizhen Liang, Tao Xie, Yonghui Shen, Yanjing Cao, Effects of Rivastigmine Combined with Reinhartdt and Sea Cucumber Capsule in Patients with Mild-to-Moderate Parkinson’s Disease Dementia: A Pilot Study, Chinese Medicine, 2014, 05, 02, 94

    CrossRef

  8. 8
    Susan E. Merel, Shaune DeMers, Elizabeth Vig, Palliative Care in Advanced Dementia, Clinics in Geriatric Medicine, 2014, 30, 3, 469

    CrossRef

  9. 9
    Shaune DeMers, Kyl Dinsio, Whitney Carlson, Psychiatric Care of the Older Adult, Medical Clinics of North America, 2014, 98, 5, 1145

    CrossRef

  10. 10
    Therapie Psychischer Erkrankungen, 2014,

    CrossRef

  11. 11
    Shin-ichi Uchida, Takako Kadowaki-Horita, Tomoyuki Kanda, Adenosine Receptors in Neurology and Psychiatry, 2014,

    CrossRef

  12. 12
    Natalie C. Palavra, Sharon L. Naismith, Simon J. G. Lewis, Mild Cognitive Impairment in Parkinson’s Disease: A Review of Current Concepts, Neurology Research International, 2013, 2013, 1

    CrossRef

  13. 13
    Stefan Lorenzl, Georg Nübling, Klaus Maria Perrar, Raymond Voltz, Ethical and Legal Issues in Neurology, 2013,

    CrossRef

  14. 14
    Per Svenningsson, Eric Westman, Clive Ballard, Dag Aarsland, Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment, The Lancet Neurology, 2012, 11, 8, 697

    CrossRef

  15. 15
    Ying Li, Shan Hai, Yan Zhou, Bi Rong Dong, Cholinesterase inhibitors for neurological conditions associated with rarer dementias, The Cochrane Library,
  16. 16
    Ying Li, Shan Hai, Yan Zhou, Bi Rong Dong, Cholinesterase inhibitors for rarer dementias associated with neurological conditions, The Cochrane Library,
  17. 17
    D. P. Devanand, Cognitive Enhancers and Treatments for Alzheimer's Disease,
  18. 18
    Christopher Bunt, In people with Parkinson's disease dementia (PDD), Parkinson's disease cognitive impairment (CIND-PD), or dementia with Lewy bodies (DLB), what are the effects of cholinesterase inhibitors?, Cochrane Clinical Answers,
  19. 19
    Bruce A Fage, Dallas P Seitz, Sudeep S Gill, Nathan Herrmann, Nadja Smailagic, Calvin CH Chan, Vasilis Nikolaou, Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting, The Cochrane Library,
  20. 20
    Bruce A Fage, Calvin CH Chan, Sudeep S Gill, Anna H Noel-Storr, Nathan Herrmann, Nadja Smailagic, Vasilis Nikolaou, Dallas P Seitz, Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community setting, The Cochrane Library,
  21. 21
    Calvin CH Chan, Bruce A Fage, Nadja Smailagic, Sudeep S Gill, Nathan Herrmann, Vasilis Nikolaou, Dallas P Seitz, Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care setting, The Cochrane Library,